Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Abgenix, Inc., Fremont, CA, United States
Search 27 grants from Anne Messer
Search grants from Abgenix, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
Gut Microbial and Metabolic Mediators of Rotavirus Vaccine Response
Protocol-Specific Research Support
Role of histone acetyltransferases in memory storage and synaptic plasticity
Evaluation of Neural Implantation Spinal Cord Injury
Recently added grants:
Mouse modeling of HPV infection
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
Dissecting the role of PTEN in human disease by testing the effects of thousands of variants on multiple cellular phenotypes
Defining mechanisms of resistance to hormonal therapy in breast cancer
Competition, Bundled Care Payment, and Low-Value Cancer Care
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
7R42NS038002-03
Application #
6351866
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2003-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$250,000
Indirect Cost
Institution
Name
Abgenix, Inc.
Department
Type
DUNS #
City
Fremont
State
CA
Country
United States
Zip Code
94555
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant